Publication & Citation Trends
Publications
0 total
Novel Maintenance Therapeutic for Opioid Use Disorder
Cited by 0
Semantic Scholar
EPD1504: a novel μ-opioid receptor partial agonist attenuates obsessive–compulsive disorder (OCD)-like behaviors OA
Cited by 1
Semantic Scholar
A Novel Maintenance Therapeutic for Opioid Use Disorder OA
Cited by 3
Semantic Scholar
In Vitro Pharmacological Characterization and In Vivo Validation of LSN3172176 a Novel M1 Selective Muscarinic Receptor Agonist Tracer Molecule for Positron Emission Tomography OA
Cited by 13
Semantic Scholar
Preclinical evaluation of the kappa-opioid receptor antagonist CERC-501 as a candidate therapeutic for alcohol use disorders OA
Cited by 68
Semantic Scholar
The novel kappa opioid receptor antagonist CERC-501 attenuates alcohol seeking and withdrawal anxiety
Cited by 0
Semantic Scholar
An Allosteric Potentiator of the Dopamine D1 Receptor Increases Locomotor Activity in Human D1 Knock-In Mice without Causing Stereotypy or Tachyphylaxis OA
Cited by 41
Semantic Scholar
Targeted Blockade of TARP-γ8-Associated AMPA Receptors: Anticonvulsant Activity with the Selective Antagonist LY3130481 (CERC-611).
Cited by 13
Semantic Scholar
Research Topics
Receptor Mechanisms and Signaling
(94)
Neuropeptides and Animal Physiology
(93)
Neuroscience and Neuropharmacology Research
(42)
Regulation of Appetite and Obesity
(26)
Neurotransmitter Receptor Influence on Behavior
(25)
Affiliations
Uppsala University
National Institutes of Health
University of Arizona
Eli Lilly (United States)
University of Utah